Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (272 million pounds) over five years over Washington's insistence on sensitive data.
This move was revealed after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since clarified that the United States was demanding access to health data for scientific study and commercial gain while was not willing to share the benefits from future treatments.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for more dialogue to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Context
This rejection comes after a similar situation in Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.
Based on statements, 16 African countries have to date signed these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our people if a new pandemic emerge."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its push of bilateral deals were undermining structures already set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This mechanism is designed to ensure that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent collaboration might be arranged in a way that honours the independence and interests of both nations."
Health Experts Response
A leading public health body said it acknowledged the official position, but recommended that talks should continue given that a large portion of the country's HIV programmes were funded by foreign aid.
"Where technical issues arise, including those relating to information security or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group commented.
The halted deal highlights the complex challenges between accepting vital international aid and protecting a country's data in an ever more interconnected world.